Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-01-04

Clinical Trial Update: Immune Monitoring on Sipuleucel-T

View source ↗

Summary

This clinical trial update reports immune monitoring findings from a completed trial of sipuleucel-T in prostate cancer, highlighting immune responses observed …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • sipuleucel-T (sipuleucel-T)

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Prostate Cancer | Status: COMPLETED